- Home
- ANEB vs CLPS Comparison
ANEB vs CLPS Comparison
Compare ANEB & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- CLPS
- Stock Information
- Founded
- ANEB 2020
- CLPS 2005
- Country
- ANEB United States
- CLPS Hong Kong
- Employees
- ANEB N/A
- CLPS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- ANEB Health Care
- CLPS Technology
- Exchange
- ANEB Nasdaq
- CLPS Nasdaq
- Market Cap
- ANEB 111.8M
- CLPS 29.7M
- IPO Year
- ANEB 2021
- CLPS 2018
- Fundamental
- Price
- ANEB $2.75
- CLPS $0.94
- Analyst Decision
- ANEB Buy
- CLPS
- Analyst Count
- ANEB 2
- CLPS 0
- Target Price
- ANEB $8.00
- CLPS N/A
- AVG Volume (30 Days)
- ANEB 25.7K
- CLPS 286.6K
- Earning Date
- ANEB 11-12-2025
- CLPS 10-17-2025
- Dividend Yield
- ANEB N/A
- CLPS 13.54%
- EPS Growth
- ANEB N/A
- CLPS N/A
- EPS
- ANEB N/A
- CLPS N/A
- Revenue
- ANEB N/A
- CLPS $164,481,414.00
- Revenue This Year
- ANEB N/A
- CLPS N/A
- Revenue Next Year
- ANEB N/A
- CLPS N/A
- P/E Ratio
- ANEB N/A
- CLPS N/A
- Revenue Growth
- ANEB N/A
- CLPS 15.17
- 52 Week Low
- ANEB $0.80
- CLPS $0.80
- 52 Week High
- ANEB $3.42
- CLPS $1.88
- Technical
- Relative Strength Index (RSI)
- ANEB 62.06
- CLPS 43.27
- Support Level
- ANEB $2.50
- CLPS $0.89
- Resistance Level
- ANEB $2.76
- CLPS $1.88
- Average True Range (ATR)
- ANEB 0.13
- CLPS 0.14
- MACD
- ANEB 0.04
- CLPS -0.03
- Stochastic Oscillator
- ANEB 79.03
- CLPS 0.67
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.